Senti Biosciences Holdings, Inc. cotiza a 0.32 USD y tiene una capitalización bursátil de $10M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.14 | $-0.53 | $-0.69 | $-0.56 |
| Estimado | $-0.36 | $-0.47 | $-0.57 | $-0.90 |
| Sorpresa | +61.1% | -12.8% | -21.1% | +37.8% |
| Métrica | SNTI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -312631.8% | -38.6% | -312593.2% |
| Net Margin | -279263.6% | -33.6% | -279230.1% |
| FCF Margin | -198363.6% | -13.9% | -198349.8% |
| ROE | -1099.3% | -40.4% | -1058.9% |
| ROA | -119.9% | -32.0% | -87.9% |
| Current Ratio | 1.67 | 2.84 | -1.17 |
| Debt / Equity | — | 0.28 | — |